Brainstorm Cell Therapeutics Inc

BCLI.US
Healthcare · Biotechnology
0.90
-0.10 (-9.73%)
USD · NASDAQ

Company Information

Company Name
Brainstorm Cell Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US10501E2019
CIK: 0001137883
CUSIP: 10501E102
Currency: USD
Full Time Employees: 19
Phone: 201 488 0460
Fiscal Year End: December
IPO Date: Aug 28, 2003
Description:

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company's NurOwn proprietary cell therapy platform that leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is involved in the development of NurOwn, which has completed Phase IIIb clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of Alzheimer's disease, as well as for treatment of other neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.

Address:

1325 Avenue of Americas, New York, NY, United States, 10019

People

Directors & Officers

Name Title Year Born
Mr. Chaim Lebovits President & CEO 1971
Dr. Ibrahim B. Dagher M.D. Executive VP & Chief Medical Officer 1969
Mr. Uri Yablonka Executive VP, Chief Business Officer, Secretary & Director 1977
Ms. Alla Patlis CPA, M.B.A. Interim CFO & Controller 1987
Dr. Hartoun Hartounian Ph.D. Executive VP & COO 1960
Ms. Mary Kay Turner Senior Vice President of Patient Advocacy & Government Affairs NA
Dr. Netta Blondheim-Shraga Ph.D. Senior Vice President of Research and Development NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 30, 2024 Chaim Lebovits N/A Purchase 1.47K $3.45 $5.06K
Jul 19, 2024 Ibrahim B. Dagher N/A Sale 4.20K $5.25 $22.05K
Sep 01, 2023 Stacy Lindborg N/A Purchase 766.00 $26.55 $20.34K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BNP Paribas Arbitrage, SA 0.00 Dec 31, 2025 0.00% $0.00 -100.00%
VSM Wealth Advisory, LLC 0.00 Dec 31, 2025 0.00% $0.00 -100.00%
Advisor Group Holdings, Inc. 0.00 Dec 31, 2025 0.00% $0.00 -100.00%
St Germain D J Co Inc 0.00 Dec 31, 2025 0.00% $0.00 -100.00%
Steward Partners Investment Advisory, LLC 0.00 Dec 31, 2025 0.00% $0.00 -100.00%
Bangor Savings Bank 0.00 Dec 31, 2025 0.00% $0.00 -100.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Extended Equity Market Fund B 4.80K 0.04% ▲ 0.00% Jun 30, 2025

Financial Highlights

Market Cap: $10.26M
EBITDA: $-8.73M
PEG Ratio: $0.00
Book Value: $-1.00
Earnings/Share: $-0.85
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -257.46%
ROE (TTM): -1,121.90%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $12.07M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 11.03M
Shares Float: 9.92M
% Insiders: 1,027.00%
% Institutions: 0.00%
Short % Float: 6.46%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$703.00K
Gross Profit
subtotal
$703.00K
SG&A
adjust
$-5.78M
R&D
adjust
$-4.18M
Operating Income
subtotal
$-9.95M
Other / Non-Operating Items
adjust
$-354.00K
Net Income
subtotal
$-10.31M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about BCLI.US!